Search research articles
Contact Us
Filters
Showing results (61-70 of 976) with videos related to
Page
of 98
Sort By:
Lancet (London, England)
|
May 22, 2002
Chronic fatigue syndrome and myalgic encephalomyelitis
Judith B Prins, Gijs Bleijenberg, Jos W M van der Meer
Advances in Experimental Medicine and Biology
|
August 15, 2003
Pro-inflammatory cytokine response in acute infection
Bachti Alisjahbana, Mihai G Netea, Jos W M van der Meer
Clinical Chemistry and Laboratory Medicine
|
May 23, 2020
Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data
Martine J Hollestelle, Felix J M van der Meer, Piet Meijer
The Netherlands Journal of Medicine
|
April 9, 2005
Side effects of anticytokine strategies
J W M van der Meer, C Popa, M G Netea
Molecular Medicine (Cambridge, Mass.)
|
January 29, 2011
Effects of the histone deacetylase inhibitor ITF2357 in autoinflammatory syndromes
Evelien J Bodar, Anna Simon, Jos W M van der Meer
Lancet (London, England)
|
January 31, 2006
Chronic fatigue syndrome
Judith B Prins, Jos W M van der Meer, Gijs Bleijenberg
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 2, 2012
Vermeer and Leeuwenhoek, figments of the imagination?
Jos W M van der Meer, Anne Lenders, Pilar Barrera Rico
Nature Reviews. Drug Discovery
|
August 2, 2012
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Charles A Dinarello, Anna Simon, Jos W M van der Meer
Science Translational Medicine
|
January 17, 2014
Comment on "Power of rare diseases: found in translation"
Jos W M van der Meer, Anna Simon, Charles A Dinarello
BMC Public Health
|
December 21, 2010
Smoking cessation quitlines in Europe: matching services to callers' characteristics
Marc C Willemsen, Regina M van der Meer, Gerard M Schippers
Page
of 98
Search research articles
Search
Showing results (61-70 of 976) with videos related to
Sort By:
Page
of 98
Lancet (London, England)
|
May 22, 2002
Chronic fatigue syndrome and myalgic encephalomyelitis
Judith B Prins, Gijs Bleijenberg, Jos W M van der Meer
Advances in Experimental Medicine and Biology
|
August 15, 2003
Pro-inflammatory cytokine response in acute infection
Bachti Alisjahbana, Mihai G Netea, Jos W M van der Meer
Clinical Chemistry and Laboratory Medicine
|
May 23, 2020
Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data
Martine J Hollestelle, Felix J M van der Meer, Piet Meijer
The Netherlands Journal of Medicine
|
April 9, 2005
Side effects of anticytokine strategies
J W M van der Meer, C Popa, M G Netea
Molecular Medicine (Cambridge, Mass.)
|
January 29, 2011
Effects of the histone deacetylase inhibitor ITF2357 in autoinflammatory syndromes
Evelien J Bodar, Anna Simon, Jos W M van der Meer
Lancet (London, England)
|
January 31, 2006
Chronic fatigue syndrome
Judith B Prins, Jos W M van der Meer, Gijs Bleijenberg
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 2, 2012
Vermeer and Leeuwenhoek, figments of the imagination?
Jos W M van der Meer, Anne Lenders, Pilar Barrera Rico
Nature Reviews. Drug Discovery
|
August 2, 2012
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Charles A Dinarello, Anna Simon, Jos W M van der Meer
Science Translational Medicine
|
January 17, 2014
Comment on "Power of rare diseases: found in translation"
Jos W M van der Meer, Anna Simon, Charles A Dinarello
BMC Public Health
|
December 21, 2010
Smoking cessation quitlines in Europe: matching services to callers' characteristics
Marc C Willemsen, Regina M van der Meer, Gerard M Schippers
Page
of 98